Lowest-Rated StocksLowest-RatedNASDAQ:DOCS Doximity (DOCS) Stock Price, News & Analysis $28.19 +0.17 (+0.61%) (As of 07/26/2024 ET) Add Compare Share Share Today's Range$27.66▼$28.5150-Day Range$26.37▼$29.8852-Week Range$19.71▼$36.03Volume1.04 million shsAverage Volume1.32 million shsMarket Capitalization$5.23 billionP/E Ratio39.15Dividend YieldN/APrice Target$28.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsTrends Get Doximity alerts: Email Address Doximity MarketRank™ Stock AnalysisAnalyst RatingHold2.07 Rating ScoreUpside/Downside0.7% Downside$28.00 Price TargetShort InterestN/ADividend StrengthN/ASustainabilityN/ANews Sentiment0.56Based on 13 Articles This WeekInsider TradingSelling Shares$1.37 M Sold Last QuarterProj. Earnings Growth10.81%From $0.74 to $0.82 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.1.37 out of 5 starsMedical Sector724th out of 936 stocksCustom Computer Programming Services Industry19th out of 26 stocks 1.0 Analyst's Opinion Consensus RatingDoximity has received a consensus rating of Hold. The company's average rating score is 2.07, and is based on 3 buy ratings, 10 hold ratings, and 2 sell ratings.Amount of Analyst CoverageDoximity has only been the subject of 4 research reports in the past 90 days.Read more about Doximity's stock forecast and price target. Previous Next N/A Short Interest Short InterestThere is no current short interest data available for DOCS. Previous Next 0.0 Dividend Strength Dividend YieldDoximity does not currently pay a dividend.Dividend GrowthDoximity does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for DOCS. Previous Next 2.0 News and Social Media Coverage News SentimentDoximity has a news sentiment score of 0.56. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.News Coverage This WeekMarketBeat has tracked 13 news articles for Doximity this week, compared to 6 articles on an average week.Search InterestOnly 1 people have searched for DOCS on MarketBeat in the last 30 days. This is a decrease of -90% compared to the previous 30 days.MarketBeat FollowsOnly 3 people have added Doximity to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days. Previous Next 4.2 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Doximity insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $1,373,825.00 in company stock.Percentage Held by Insiders39.40% of the stock of Doximity is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions87.19% of the stock of Doximity is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Doximity's insider trading history. Previous Next 2.5 Earnings and Valuation Earnings GrowthEarnings for Doximity are expected to grow by 10.81% in the coming year, from $0.74 to $0.82 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Doximity is 39.15, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 133.27.Price to Earnings Ratio vs. SectorThe P/E ratio of Doximity is 39.15, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 112.08.Price to Earnings Growth RatioDoximity has a PEG Ratio of 5.21. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioDoximity has a P/B Ratio of 5.84. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Doximity's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad American Hartford Gold GroupPrepare for a Recession Unlike Any OtherDave Ramsey Is Dangerously Wrong And Here’s Why>> Asked whether we’re on the cusp of a US Dollar crash, Dave Ramsey made a stunning miscalculation while live on air: “Am I worried about this? Absolutely not.” Frankly, I've never seen someone so confident in being wrong… Because what’s happening to the US Dollar is not something you should “keep an eye on”… But instead, is an imminent threat you should get ahead of right NOW.GET THE FREE GUIDE About Doximity Stock (NASDAQ:DOCS)Doximity, Inc. operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers. It primarily serves pharmaceutical manufacturers and healthcare systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.Read More DOCS Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart DOCS Stock News HeadlinesJuly 4, 2024 | insidertrades.comKira Scherer Wampler Sells 2,500 Shares of Doximity, Inc. (NASDAQ:DOCS) StockJuly 3, 2024 | insidertrades.comDoximity, Inc. (NASDAQ:DOCS) Director Sells $70,000.00 in StockJuly 27, 2024 | True Market Insiders (Ad)The #1 Crypto for 2024 (3 Cent Coin)Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 different coins that have returned over 100%... Today, he is now making the biggest crypto call of his ENTIRE career…July 26 at 8:18 PM | 247wallst.comDoximity Inc - Class AJuly 25 at 11:03 AM | msn.comDoximity (DOCS) Stock Moves -1.24%: What You Should KnowJuly 23, 2024 | markets.businessinsider.comDoximity: Hold Rating Amid Mixed Signals in Pharmaceutical Advertising SpendJuly 23, 2024 | seekingalpha.comDoximity Faces Slower Revenue Growth As R&D Costs May RiseJuly 20, 2024 | americanbankingnews.comDoximity (NASDAQ:DOCS) Shares Gap Down to $28.99July 27, 2024 | True Market Insiders (Ad)The #1 Crypto for 2024 (3 Cent Coin)Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 different coins that have returned over 100%... Today, he is now making the biggest crypto call of his ENTIRE career…July 20, 2024 | ca.finance.yahoo.comDOCS Aug 2024 40.000 callJuly 20, 2024 | ca.finance.yahoo.comDOCS Aug 2024 25.000 putJuly 20, 2024 | markets.businessinsider.comCracking The Code: Understanding Analyst Reviews For DoximityJuly 20, 2024 | markets.businessinsider.comEvercore ISI Reaffirms Their Hold Rating on Doximity (DOCS)July 20, 2024 | msn.comWells Fargo Downgrades Doximity (DOCS)July 18, 2024 | americanbankingnews.comDoximity (NASDAQ:DOCS) Downgraded by Wells Fargo & Company to "Underweight"June 19, 2024 | globenewswire.comDOXIMITY ALERT: Bragar Eagel & Squire, P.C. is Investigating Doximity, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the FirmJune 17, 2024 | businesswire.comDOCS Investors Have Opportunity to Lead Doximity, Inc. Securities Fraud Lawsuit with the Schall Law FirmJune 14, 2024 | globenewswire.comDOCS DEADLINE MONDAY: ROSEN, A TOP RANKED LAW FIRM, Encourages Doximity, Inc. Investors to Secure Counsel Before Important June 17 Deadline in Securities Class Action – DOCSSee More Headlines Receive DOCS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Doximity and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/16/2024Today7/27/2024Next Earnings (Confirmed)8/08/2024Fiscal Year End3/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Custom computer programming services Sub-IndustryN/A Current SymbolNASDAQ:DOCS CUSIPN/A CIK1516513 Webwww.doximity.com Phone650-549-4330FaxN/AEmployees977Year FoundedN/APrice Target and Rating Average Stock Price Target$28.00 High Stock Price Target$33.00 Low Stock Price Target$19.00 Potential Upside/Downside-0.7%Consensus RatingHold Rating Score (0-4)2.07 Research Coverage15 Analysts Profitability EPS (Most Recent Fiscal Year)$0.72 Trailing P/E Ratio39.15 Forward P/E Ratio38.09 P/E Growth5.21Net Income$147.58 million Net Margins31.04% Pretax Margin38.96% Return on Equity17.44% Return on Assets14.85% Debt Debt-to-Equity RatioN/A Current Ratio6.20 Quick Ratio6.20 Sales & Book Value Annual Sales$475.42 million Price / Sales10.99 Cash Flow$0.93 per share Price / Cash Flow30.23 Book Value$4.83 per share Price / Book5.84Miscellaneous Outstanding Shares185,426,000Free Float112,368,000Market Cap$5.23 billion OptionableNot Optionable Beta1.22 The 10 Best AI Stocks to Own in 2024Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free Report Key ExecutivesMr. Jeffrey A. Tangney (Age 51)Co-Founder, CEO & Chairperson Comp: $243.73kDr. Nate Gross M.D. (Age 40)Co-Founder & Chief Strategy Officer Comp: $455.54kMs. Anna Bryson (Age 34)Chief Financial Officer Comp: $453.71kMs. Jennifer W. Chaloemtiarana (Age 56)General Counsel & Corporate Secretary Comp: $504.04kMr. Paul Jorgensen (Age 53)Chief Revenue Officer Comp: $455.13kMs. Shari BuckCo-founder and SVP People & OpsMr. Jey BalachandranChief Technology OfficerMr. Perry Scott GoldHead of Investor RelationsJim RivasHead of Corporate CommunicationsMr. Bruno MirandaSenior VP of EngineeringMore ExecutivesKey CompetitorsPegasystemsNASDAQ:PEGASmartsheetNYSE:SMARFive9NASDAQ:FIVNAvalaraNYSE:AVLRTeladoc HealthNYSE:TDOCView All CompetitorsInsiders & InstitutionsBank of New York Mellon CorpBought 17,430 shares on 7/26/2024Ownership: 0.617%EFG Asset Management North America Corp.Bought 29,566 shares on 7/26/2024Ownership: 0.044%State of Michigan Retirement SystemSold 600 shares on 7/26/2024Ownership: 0.016%Allspring Global Investments Holdings LLCSold 833 shares on 7/26/2024Ownership: 0.011%Baillie Gifford & Co.Sold 319,793 shares on 7/25/2024Ownership: 3.180%View All Insider TransactionsView All Institutional Transactions DOCS Stock Analysis - Frequently Asked Questions How have DOCS shares performed this year? Doximity's stock was trading at $28.04 at the beginning of the year. Since then, DOCS shares have increased by 0.5% and is now trading at $28.19. View the best growth stocks for 2024 here. How were Doximity's earnings last quarter? Doximity, Inc. (NASDAQ:DOCS) announced its quarterly earnings data on Thursday, May, 16th. The company reported $0.20 EPS for the quarter, topping analysts' consensus estimates of $0.16 by $0.04. The firm earned $118.06 million during the quarter, compared to analysts' expectations of $116.46 million. Doximity had a net margin of 31.04% and a trailing twelve-month return on equity of 17.44%. When did Doximity IPO? Doximity (DOCS) raised $501 million in an initial public offering (IPO) on Thursday, June 24th 2021. The company issued 23,300,000 shares at $20.00-$23.00 per share. Morgan Stanley, Goldman Sachs and J.P. Morgan Securities acted as the underwriters for the IPO and Piper Sandler, William Blair, Canaccord and Raymond James were co-managers. Who are Doximity's major shareholders? Doximity's top institutional shareholders include Baillie Gifford & Co. (3.18%), Swedbank AB (0.90%), Bank of New York Mellon Corp (0.62%) and Retirement Systems of Alabama (0.08%). Insiders that own company stock include Anna Bryson, Paul W Jorgensen, Craig Overpeck, Timothy S Cabral, Kira Scherer Wampler, Gilbert H Kliman and Joseph B Kleine. View institutional ownership trends. How do I buy shares of Doximity? Shares of DOCS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:DOCS) was last updated on 7/27/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredJ.P. Morgan’s DIRE WarningWhen the largest bank in the U.S. says a crisis is coming - you NEED to listen. The Wall Street Journal war...Behind the Markets | SponsoredNext opportunity for crypto millionsThe Bitcoin halving is the #1 creator of "crypto millionaires". That's because historically, every halving has...Crypto 101 Media | SponsoredGet out of cash before the Fed's next meeting"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...Stansberry Research | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredGrab a pen and write down this ticker - here's whyA megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Doximity, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Doximity With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.